Shares of Biogen Inc. BIIB slipped 1.40% to $138.37 Friday, on what proved to be an all-around rough trading session for the ...

Biogen (BIIB) announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year ...

Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprint New building will be ...

As part of a bid to consolidate its footprint in Massachusetts, Biogen is foregoing its old home base to put down new roots in Cambridge. That said, the company won’t be moving far from its ...

“Biogen has been a foundational presence in the Massachusetts life science ecosystem for close to half a century,” said Governor Maura Healey, in a statement. “We are thrilled to see them ...

CAMBRIDGE, Mass., March 24, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a ...

Biogen signed a 585K SF lease at the 75 Broadway St. development in Cambridge, the company announced Monday morning. It plans to move to the building in 2028 as its global headquarters.

With a market cap of $21 billion, Cambridge, Massachusetts-based Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative ...

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprint New building will be ...